GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
46.86
-0.08 (-0.17%)
At close: Oct 31, 2025, 4:00 PM EDT
46.87
+0.01 (0.02%)
After-hours: Oct 31, 2025, 7:28 PM EDT
GSK Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for GSK in the last 12 months.
Price Target: n/a
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GSK stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Initiates n/a | Hold → Strong Buy | Initiates | n/a | n/a | Oct 27, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +13.10% | Jul 2, 2024 |
Financial Forecast
Revenue This Year
33.10B
from 31.38B
Increased by 5.50%
Revenue Next Year
34.82B
from 33.10B
Increased by 5.21%
EPS This Year
1.67
from 0.62
Increased by 168.63%
EPS Next Year
1.80
from 1.67
Increased by 7.47%
Financial currency is GBP. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 34.6B | 37.4B | |||
| Avg | 33.1B | 34.8B | |||
| Low | 31.0B | 32.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.4% | 13.1% | |||
| Avg | 5.5% | 5.2% | |||
| Low | -1.1% | -2.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.84 | 2.10 | |||
| Avg | 1.67 | 1.80 | |||
| Low | 1.32 | 0.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 195.9% | 25.7% | |||
| Avg | 168.6% | 7.5% | |||
| Low | 112.1% | -58.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.